[quick news] Friday, December 15, 2017

After 22 years in office, Dr Philip Campbell, the seventh editor in chief since the founding of nature, will be the general editor of Springer nature group in 2018, responsible for the editorial policy of the whole group In 2001, Dr Campbell directed and published the well-known sketch of human genome sequence After the merger of Springer and nature in 2015, Dr Campbell was responsible for the creation of Springer nature editorial advisory group to supervise and formulate editorial policies and standards for the whole group Talking new media http://www.talkingnewmedia.com/2017/12/13/new-editor-brief-nature-sound-sir-philip-campbell-moves-newly-created-role-within-springer-nature/scientists find the main cause of dementia The latest research by an international team of scientists from the United States, the United Kingdom and Australia shows that there is a direct relationship between brain urea levels and metabolic processes and Huntington's disease In a 2016 study, the team found a similar link between urea and Alzheimer's Alzheimer's disease and Huntington's disease are at both ends of the dementia spectrum If this conclusion is applicable to these two diseases, it is likely to be applicable to all dementia related to aging PNAs http://www.pnas.org/content/early/2017/12/05/1711243115 Abstract? Sid = f65b7ebb-627d-4fcb-9d20-fbfbfb695b12f4 the UK will pilot the undergraduate two-year system of University recently, Jo Johnson, under secretary of education and science affairs of UK university, said that reducing the typical school system from three years to two-year system will greatly reduce the cost of students, and all majors will be the same The measure will save college students 25000 pounds in tuition fees and help them find jobs faster after graduation At the beginning of the measures, only 2500 students will enter the "diploma fast track" Compared with the total enrollment of 1.5 million people every year, 2500 people are only a small number Mirror http://www.mirror.co.uk/news/uk-news/university-leaders-gearing-up-two-11667213 regorafenib was approved as the first new second-line liver cancer drug in China The State Food and Drug Administration (CFDA) approved Bayer's oral multi kinase inhibitor regorafenib (trade name: bavango ®) for use in patients with HCC who had previously received sorafenib treatment It is also the first new drug approved for second-line treatment of HCC in China Regiofenib is a kinase inhibitor, which can inhibit a variety of enzymes promoting tumor growth, including those involved in vascular endothelial growth factor pathway Bayer Greater China http://www.bayer.com.cn/index.php/newscenter/newsdetail/id/440 nanometer probe to track cancer spread or better than MRI scientists at Rutgers University in the United States invented a nanometer probe, which uses luminescent nanoparticles to emit short wave infrared light in the blood to detect small tumors and track their spread Mouse experiments showed that the effect of MRI was better than that of MRI in detecting the micro damage of adrenal gland and bone and the micro diffusion of tumor The technology can be used to detect and track more than 100 types of cancer as cells spread to any part of the body Futurity http://www.futurity.org/nanoparticles-detect-cancer-1630312/